Rita Jain - 03 Apr 2023 Form 4 Insider Report for ANAPTYSBIO, INC (ANAB)

Role
Director
Signature
/s/ Eric Loumeau, Attorney-in-Fact
Issuer symbol
ANAB
Transactions as of
03 Apr 2023
Transactions value $
$0
Form type
4
Filing time
06 Apr 2023, 17:05:43 UTC
Previous filing
21 Feb 2023
Next filing
27 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANAB Stock Option (right to buy) Award $0 +10,600 $0 10,600 03 Apr 2023 Common Stock 10,600 $22.09 Direct F1
transaction ANAB Stock Option (right to buy) Award $0 +8,015 $0 8,015 03 Apr 2023 Common Stock 8,015 $22.09 Direct F2
transaction ANAB Restricted Stock Unit Award $0 +3,900 $0 3,900 03 Apr 2023 Common Stock 3,900 Direct F3, F4
transaction ANAB Restricted Stock Unit Award $0 +3,234 $0 3,234 03 Apr 2023 Common Stock 3,234 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as of 1/36 of the total shares monthly beginning on May 6, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F2 The stock option vests as of 1/9 of the total shares monthly beginning on May 6, 2023 and each month thereafter until fully vested on January 6, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F4 The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date.
F5 The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.